ATI RN
ATI Pharmacology 2023 Questions
Question 1 of 5
A nurse is caring for a client who is receiving parenteral nutrition and identifies that the client has hypoglycemia. Which of the following actions should the nurse take?
Correct Answer: B
Rationale: The correct answer is B: Administer IV dextrose. Hypoglycemia in a client receiving parenteral nutrition indicates low blood sugar levels, which can lead to serious complications. Administering IV dextrose is crucial to rapidly increase the client's blood glucose levels and prevent further hypoglycemia-related issues. Discontinuing the infusion (
Choice
A) would worsen the hypoglycemia. Warming formula to room temperature (
Choice
C) and obtaining arterial blood gases (
Choice
D) are not directly related to treating hypoglycemia in this scenario.
Question 2 of 5
A nurse is preparing to administer a medication to a client. Using the rights of medication administration. Which of the following actions should the nurse take to ensure the right medication is administered to the client?
Correct Answer: C
Rationale: The correct answer is C: Use two client identifiers prior to administering the medication. This is crucial to ensure that the right medication is administered to the right client. By using two identifiers, such as the client's name and date of birth, the nurse can double-check and verify the client's identity before giving the medication. This helps prevent medication errors and ensures patient safety.
Choice A is incorrect because asking another nurse to check the medication dosage is related to verifying the right dose, not the right medication.
Choice B is incorrect because verifying a written order with the medication administration record is important but does not specifically ensure the right medication is administered.
Choice D is incorrect because documenting the medication after administration does not prevent errors in medication administration.
Question 3 of 5
A nurse is caring for a client in the post-anesthesia unit who is experiencing malignant hyperthermia. Which of the following prescriptions should the nurse anticipate administering?
Correct Answer: D
Rationale: The correct answer is D: Dantrolene. Dantrolene is the drug of choice for treating malignant hyperthermia, a rare but life-threatening condition triggered by certain medications used during anesthesia. Dantrolene works by inhibiting the release of calcium from the sarcoplasmic reticulum in skeletal muscle cells, which helps to reduce muscle contractions and hyperthermia. Verapamil (
A) is a calcium channel blocker used for different purposes. Naloxone (
B) is an opioid antagonist used for opioid overdoses. Cefazolin (
C) is an antibiotic used for treating infections. In summary, Dantrolene is the appropriate choice for managing malignant hyperthermia due to its mechanism of action in preventing further muscle contraction and hyperthermia.
Question 4 of 5
A nurse is preparing to transcribe a prescription for a client that reads 'ondansetron 8 mg by mouth every 12 hr PRN.' Which of the following parts of the prescription should the nurse clarify with the provider?
Correct Answer: D
Rationale: The correct answer is D: Reason. The nurse should clarify the reason for the prescription with the provider because it is important to understand the underlying condition or symptoms the medication is intended to treat. This information helps ensure the appropriateness of the prescription and aids in monitoring the client's response to the medication. Clarifying the dose (
A), route (
B), and frequency (
C) are essential but the reason (
D) behind the prescription is crucial for safe and effective medication administration.
Choices E, F, and G are not applicable in this scenario.
Question 5 of 5
A nurse is caring for a client who is taking warfarin and reports taking several new herbal supplements. The nurse should identify which of the following supplements is contraindicated for concurrent use with warfarin?
Correct Answer: A
Rationale: The correct answer is A: Ginkgo biloba. Ginkgo biloba can increase the risk of bleeding when taken with warfarin due to its anticoagulant properties, potentially leading to serious complications. Coenzyme Q10 (
Choice
B), Valerian (
Choice
C), and Probiotics (
Choice
D) do not have significant interactions with warfarin. Ginkgo biloba is the only supplement in the list known to interact adversely with warfarin.